Summary:
The study is approximately 18-22 weeks long. There will be 9 visits. The investigational medication is an extended release form of metformin to be added on to your current diabetes treatment or in place of your current metformin treatment.
Qualified Participants Must:
• Have Type 2 diabetes
•
Be between 25 and 65 years of age
•
Are being treated with diet and/or certain oral diabetes medications which have been stable for at least 3 months
•
Not be on insulin, Victoza, Byetta, Trulicity
Qualified Participants May Receive:
Total Compensation is $450.